Search
Priory Street
Coventry CV1 5FB
United Kingdom
Tel: +44 (0)24 7765 6565
Search
The A1R is a high-value drug target but is linked to serious cardiovascular side effects because it activates multiple G proteins.
Professor Mark Wheatley and collaborators from Aston University, Dr John Simms and Professor David Poyner, have been awarded a grant of £177,497 from the BBSRC Follow-on Fund to develop new technology that will potentially revolutionise the drug discovery process.
This research considers ways we can deliberately “manipulate” our predictive brains by using various interventions to modify our beliefs/expectations about an important perceptual-motor skills.
A lifestyle intervention designed by people with POTS, for people with POTS.
The commercialisation of Professor Maddock's academic research started with a vision that there was a fundamental need within the Pharmaceutical Industry for the development of improved physiological relevant model to assess cardiac contractility.
Dr Christopher Mee's project looking at the ability of the liver to fully regenerate after injury.
Professor Mark Wheatley and collaborators have been awarded a grant from the BBSRC to investigate the G-protein-coupled receptor (GPCR) family of proteins.
This project focused on enhancing physical activity with aging people through recreational football activities.
The main focus of CARD is to support allied health professionals working in the NHS undertake translational research, particularly in the field of nursing.
Using Real-Time Cell Metabolic Analysis to establish how physiological and pathophysiological concentrations of FA impact mitochondrial function, capacity and substrate utilisation in human skeletal muscle cells.
The pituitary lactogenic hormone prolactin (Prl) has well recognised physiological actions in humans and rodents in lactation and reproduction.
In partnership with AAS, Coventry University are developing innovative and sustainable bioleaching-based processes to recover critical metals from superalloy by-products at AAS.
The goal of the project is to identify and subsequently characterise the dsRNA dimension of the animal gut microflora (both the differential presence of antisense bound to mRNA and phage dsRNAs containing novel genetic information in response to AB pressure). Identification of novel functional dsRNAs (asRNA bound to its target and phage dsRNAs involved in AR) will mark a paradigm shift in our understanding of the development of AR and future approaches to treating infections.
The aim of the project is to develop a framework and valid tools that support the delivery of physical activity pathways across England. Physical activity pathways support people with/at risk of health conditions to become more active.
This project is a pilot of a teacher training intervention to deliver student-centred motor learning pedagogical approaches and improve primary school children’s motor competence and motivation in physical education
This study aims to characterise the molecular mechanisms and functions of a novel APT, ABHD16A.
The aim of the project is to assess heart rate variability using novel disposable ECG leads in healthy subjects, and to assess the agreement between heart rate variability measures obtained using disposable and reusable electrocardiography leads.
This partnership with SE-Recycling is developing sustainable bioleaching-based processes to recycle metals from Lithium-based batteries. This sustainable technology delivers a solution that retains precious metals in UK industry, with wider economic benefits including skills development and job creation.
The aim of the project is to develop a sustainable and environmentally friendly method to recover precious metals from electronic waste that will create a closed-loop system to recycle metals back into the supply chain as required in a sustainable circular economy.
Priory Street
Coventry CV1 5FB
United Kingdom
Tel: +44 (0)24 7765 6565
